2022-2030 Oligonucleotide Synthesis Market Research Report - Regional Analysis, Top Players, Growth, Shares, Revenue

Detailed TOC of 2022-2030 Oligonucleotide Synthesis Market Research Report - Regional Analysis, Top Players, Growth, Shares, Revenue

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
6.1.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
6.2 Market Restraints
6.2.1 Price Erosion of Synthesized Oligonucleotides
6.2.2 Lack of a Unified Set of Regulations for Therapeutic Oligonucleotides
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Application
7.1.1 Research
7.1.1.1 PCR
7.1.1.2 QPCR
7.1.1.3 Sequencing
7.1.1.4 Gene Synthesis
7.1.1.5 Others
7.1.2 Diagnostics
7.1.3 Therapeutics
7.1.3.1 RNAi
7.1.3.2 Nucleic Acid Aptamers
7.1.3.3 DNA/Antisense Oligonucleotides
7.1.3.4 Immunotherapy Applications
7.2 By End User
7.2.1 Academic Research Institutes
7.2.2 Pharmaceutical and Biotechnology Companies
7.2.3 Diagnostic Laboratories
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Agilent Technologies
9.2 ATDBio
9.3 Bioautomation
9.4 Eurofins Genomics
9.5 Eurogentec
9.6 GE Healthcare
9.7 Genscript
9.8 Integrated DNA Technologies
9.9 Merck KGaA
9.10 Thermo Fisher Scientific
*List Not Exhaustive
10. Future of the Market